Tech Company Financing Transactions

ApoGen Biotechnologies Funding Round

On 8/24/2018, ApoGen Biotechnologies secured $4 million in Series A funding from M Capital and private investors.

Transaction Overview

Announced On
8/24/2018
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors

M Capital (Keno Gutierrez)

Proceeds Purpose
The company intends to use the funding from the expanded Series A to hire additional staff and establish a laboratory in Seattle.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2815 Eastlake Ave. East 300
Seattle, WA 98102
USA
Email Address
Overview
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the University of Minnesota to develop drugs that block a key pathway that causes drug resistance.
Profile
ApoGen Biotechnologies LinkedIn Company Profile
Social Media
ApoGen Biotechnologies Company Twitter Account
Company News
ApoGen Biotechnologies News
Facebook
ApoGen Biotechnologies on Facebook
YouTube
ApoGen Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Santini
  John Santini LinkedIn Profile  John Santini Twitter Account  John Santini News  John Santini on Facebook
Founder
Daniel Harki
  Daniel Harki LinkedIn Profile  Daniel Harki Twitter Account  Daniel Harki News  Daniel Harki on Facebook
Founder
Reuben Harris
  Reuben Harris LinkedIn Profile  Reuben Harris Twitter Account  Reuben Harris News  Reuben Harris on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/24/2018: MyAgData venture capital transaction
Next: 8/24/2018: Carmera venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary